Other European and Global Resources
Many organisations around the world have set up public sources of information on COVID-19, of relevant research results, or of ongoing activities to address the pandemic and its consequences.
This page presents an overview of resources to further information and initiatives that are currently ongoing from Europe and beyond.
This page was most recently updated on 16 July 2020.
Calls and funding opportunities
Several other organisations have set up overviews of COVID-19 related information, research calls, and funding opportunities from a large variety of organisations around the world:
European Institution Initiatives
A number of relevant information links and documents are available from the European Commission and other Europen institutions regarding the COVID-19 situation.
- European Commission: COVID-19 Data Portal
- European Commission: Coronavirus Response
- ERA Corona Platform
- Joint Research Centre: Science Updates
- Joint Research Centre: COVID-19 Activities
- Joint Research Centre: Data Monitoring and National Measures
- European Commission advisory panel on COVID-19
- European Open Science Cloud Fast Track Funding for COVID-19
- European Centre for Disease Prevention and Control
- Innovative Medicine Initiative (IMI)
- European Molecular Biology Laboratory (EMBL) Corona Updates
- European Institute of Innovation and Technology (EIT) Crisis Response Initiative
European Research Infrastructures
Many research infrastructures are offering prioritised access to or specific facilities for research dealing with the SARS-CoV-2 virus.
Network of European Research Infrastructures
Several research infrastructures have set up specific services, such as rapid or fast track access, to allow researchers to obtain results as soon as possible (see further below). This work is carried out by CERIC. For more information, please contact email@example.com.
Resources for researchers and labs working on COVID-19
- ACTRIS – Access to data: ACTRIS provides an insight into the European air quality and atmospheric composition during the European lockdown. See also the ACTRIS data centre, and more details about the service.
- Alba Synchrotron – Rapid access to instruments: The operations are stopped until 25 April, but the call is open, the proposals will be processed, and beam-time will be provided as soon as it will be available.
- BBMRI-ERIC – Resources from biobanks across Europe: The network of 600+ biobanks presents a list of those BBMRI national nodes and biobanks that provided specific information on the resources they can make available to researchers (academic and from the private sector) working on COVID-19. (Details about the service)
- Central European Research Infrastructure Consortium (CERIC) – Rapid access to instruments: Free remote access to NMR at National Institute of Chemistry, SAXS at Elettra and TU Graz, Cryo-EM at SOLARIS and synchrotron Elettra, following a light peer review. (Details about the service)
- Diamond Light Source – Rapid access to instruments: Priority rapid access for groups who require instrument time for projects directly related to SARS-CoV-2 viral proteins.
- EGI and EOSC Synergy – Access to a cloud computing platform: EGI and EOSC Synergy have joined forces to set up a cloud computing platform that supports COVID-19 research efforts. The platform is based on the Galaxy service and offers researchers access to datasets relevant to the ongoing investigations on the COVID-19.
- Elettra Synchrotron – Rapid access to instruments: Priority is given to experiments related to SARS-CoV-2 viral proteins and studies of possible drugs for viral infection treatment.
- ELIXIR – Data services and resources, analysis tools, compute and other services: As the ESFRI Research Infrastructure for life science data, ELIXIR Nodes provide a range of services that can be used by researchers and consortia working on SARS-CoV-2 research.
- HZB – Rapid access to instruments: BESSY II at HZB is not in user operation at present, however for corona-related research during the stand-by operation, the three MX-beamlines of HZB will be open to receiving external projects. More information about research recently done by BESSY II on Coronavirus SARS-CoV-2.
- Instruct-ERIC – Rapid access to instruments: Instruct-ERIC is the single point of access to technology and expertise for structural biology research. Priority access is offered to groups that need to use the structural biology services for projects directly related to COVID-19 viral proteins.
- ISIS Neutron and Muon Source – ISIS is not operational at present. Although ISIS has not set up a specific service to support COVID-19 research, their rapid and express routes can be used for any urgent and COVID-19-related work once they are operating again.
- MAX IV Laboratory – Rapid access to instruments: MAX IV Laboratory offers rapid access for groups who require instrument time for projects directly related to SARS-CoV-2 viral proteins such as Covid-19 related enzyme targets, membrane receptor complexes, antibody complexes etc. (ie. non-infectious samples).
- MBL-EBI – Data resources
- MLZ – Rapid Access to instruments: Special access to measurements with neutrons to study the corona virus SARS-CoV-2 or the disease COVID-19.
- Paul Scherrer Institute (PSI) – SLS and SwissFEL – Rapid access to instruments: “PRIORITY COVID-19 Call” for short proposals and quick peer review to enable rapid access to beam time.
- Petra III beamlines at DESY – Rapid access to instruments: Although PETRA III is not operating at present, they can start operation on short notice if required.
- PRACE – Rapid access to resources: PRACE is welcoming project proposals requesting computing resources to contribute to the mitigation of the impact of the COVID-19 pandemic.
- SOLEIL Synchrotron – Rapid access to instruments: Scientific research into the nature of the virus, the means to protect against it and reduce its virulence.
- TRANSVAC2 – European Vaccine Research and Development Infrastructure: Supports innovation and accelerates vaccine development by offering high-quality technical services across the R&D pipeline to academic and non-academic research groups, including SMEs. TRANSVAC2 services are free of charge with few exceptions, and can be targeted for any disease, for prophylactic, therapeutic, human and veterinary vaccines.
- Swiss Institute for Bioinformatics – SIB resources supporting SARS-CoV-2 research.
Public and Private Research Foundations
Numerous public and private research foundations are also launching activities to deal with COVID-19. Some noteworthy examples:
- COVID-19 Therapeutics Accelerator (Joint initiative sponsored by Wellcome, Bill & Melinda Gates Foundation, Chan-Zuckerberg Initiative, Michael & Susan Dell Foundation, Mastercard, and Madonna)
- Wellcome Trust
- Bill & Melinda Gates Foundation
- Chan-Zuckerberg Initiative
- Johns Hopkins Center for Alternatives to Animal Testing: Fast-Track Grant for Research on Non-Animal Approaches to Investigate Mechanisms, Medicines, and Vaccines for Coronaviruses
Journals, Publishers, and Libraries
Many research journals, publishers, and libraries are making available resources and/or publications on COVID-19 to help researchers quickly progress on results in addressing the COVID-19 pandemic.
- BMJ Coronavirus Hub
- Cambridge Academic Press: COVID-19 Resources and Information
- Clarivate Insights on COVID-19
- Cochrane Library
- CORD-19 COVID-19 Open Research Dataset
- Elsevier Novel Coronavirus Information Center
- JAMA Network COVID-19 Collection
- The Lancet COVID-19 Resource Centre
- New England Journal of Medicine: Coronavirus
- Nuffield Council on Bioethics: COVID-19
- Oxford University Press: COVID-19
- PLOS COVID-19 Updates
- Science Magazine Coronavirus Reporting
- The World Pandemic Research Network (WPRN)
Initiatives from other organisations that do not fall into one of the categories above.